BUZZ-Intellipharmaceutics International Inc: Teva to market drug in US

Mon Feb 2, 2015 11:17am EST
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

** Canadian drugmaker's U.S.-listed shares up 7.8 pct at $2.20

** Toronto-listed shares up 8.5 percent at C$2.80

** Israel-based Teva Pharmaceutical will exclusively market Intellipharmaceutics' generic oral drugs in the United States

** Intellipharmaceutics' Toronto-listed stock declined about 33 pct over last 12 months